AAV1-gamma-sarcoglycan gene therapy: Phase I data

Researchers at the hospital and colleagues reported data from an open-label, dose-escalation, French Phase I trial in 9 patients showing that a single intramuscular injection of the AAV1-gamma-sarcogl...